猫咪视频

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Warrant Activity (Details)

v3.22.2.2
Stockholders' Equity - Summary of Warrant Activity (Details) - Warrant - USD ($)
6 Months Ended 12 Months Ended
Oct. 31, 2022
Apr. 30, 2022
Number of Shares
Balance Outstanding at beginning of period (in shares) 649,174
Granted (in shares) 0
Exercised (in shares) 0
Surrendered (in shares) 0
Expired (in shares) (224,174)
Balance Outstanding at end of period (in shares) 425,000 649,174
Unvested (in shares) (16,667)
Exercisable, Number of Shares (in shares) 408,333
Weighted Average Exercise Price
Balance Outstanding at beginning of period (in dollars per share) $ 4.70
Granted (in dollars per share) 0
Exercised (in dollars per share) 0
Surrendered (in dollars per share) 0
Expired (in dollars per share) 6.87
Balance Outstanding at end of period (in dollars per share) 3.56 $ 4.70
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 3.42
Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term, Outstanding 3 years 3 months 7 days 1 year 11 months 15 days
Weighted Average Remaining Contractual Term, Exercisable 3 years 2 months 1 day
Aggregate Intrinsic Value
Average Intrinsic Value $ 0 $ 0
Aggregate Intrinsic Value, Exercisable $ 0